MO SB1767Introducedas of 2026-02-26
Modifies provisions relating to alternative therapies and treatments, including psilocybin
Plain-English summary
What happened: A Missouri bill modifying provisions on alternative therapies and treatments, including psilocybin, has been referred to the Senate Emerging Issues and Professional Registration Committee after a second reading.
Why it matters: Regulatory changes to alternative therapies, including psilocybin, could create new licensing or compliance frameworks that affect businesses and practitioners operating in that space.
Affects: cultivators and retailers and labs
LATEST ACTION: Second Read and Referred S Emerging Issues and Professional Registration Committee
READ THE FULL BILL TEXT →Follow Missouri cannabis bills for free. One plain-English email a week with every bill that moved, including this one.
Get the free digestMore Missouri cannabis bills
HB2641Creates provisions relating to cannabisPassedHB1717Modifies provisions relating to alternative therapies and treatments, including psilocybinIn CommitteeSB1682Modifies provisions relating to alternative therapies and treatments, including psilocybinIntroducedHJR103Proposes a constitutional amendment relating to the advertising and promotion of marijuana salesIntroducedSB1187Regulates the use of marijuana in public placesIntroducedHB1896Allows for early release for persons serving sentences for marijuana-related offensesIntroducedHB2765Creates provisions relating to hemp businessesIntroducedSB904Creates provisions relating to cannabisIntroduced
ALL MISSOURICANNABIS LAWS & BILLS →Legislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.